Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
AssigneeSunovion Pharmaceuticals Inc.
InventorsThomas Jerussi, Qun Kevin Fang, Mark G. Currie
Life of this patent
Estimating the term…
Abstract
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.
Claims6
A method for treating obesity, the method comprising administering to a patient in need of treatment a therapeutically effective amount of a compound of formula PQ:
- or a salt thereof.
Dependencies are inferred from the claim text.